Search Results

You searched for : LatestPharmanEWS

	Novartis India Limited signs exclusive sales and distribution agreement with Dr. Reddyâ€™s Laboratories ... Feb 14
	Asymchem Acquires Snapdragon Chemistry Latest Corporate News update ; Pharma... Feb 14
	Novo Nordisk announces completion of Dicerna Pharmaceuticals acquisition Latest pharma news update... Dec 30
	Hyloris announces FDA acceptance of new drug application for Maxigesic IV in post-operative pain Latest pharma news update... Nov 03
	Everest Medicines enters into agreement with Providence Therapeutics to advance mRNA vaccines and Therapies Latest Pharma News Update... Sep 16
	Precision BioSciences and Tiziana Life Sciences announce exclusive license agreement to evaluate Foralumab Latest pharma Update... Sep 06
	Dupixent significantly improved itch and hives in patients with chronic spontaneous urticaria Fifth disease that Dupixent has demonstrated positive pivotal results.... Jul 29
	Biocon Biologics and Viatris Inc. Receive Historic Approval for First Interchangeable Biosimilar Semglee for the Treatment of Diabetes Interchangeable Designation Allows Substitution at the Pharmacy Counter for Lantus Across the U.S. to Help Increase Access to Medicines for People Living with Diabetes... Jul 29
	Dupixent significantly improved itch and hives in patients with chronic spontaneous urticaria Fifth disease that Dupixent has demonstrated positive pivotal results.... Jul 29
	Biocon Biologics and Viatris Inc. Receive Historic Approval for First Interchangeable Biosimilar Semglee for the Treatment of Diabetes Interchangeable Designation Allows Substitution at the Pharmacy Counter for Lantus Across the U.S. to Help Increase Access to Medicines for People Living with Diabetes... Jul 29
	BioNTech to acquire Kiteâ€™s neoantigen TCR Cell Therapy R&D platform and manufacturing facility in Gaithersburg, MD Pharma merger and acquisition news... Jul 22
	Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma ... Jul 17
	Merck Announces U.S. FDA Approval of VAXNEUVANCE for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae, or pneumococcus.... Jul 17
	Status on FDA Advisory Committee vote on roxadustat in anaemia of chronic kidney disease New solutions are needed for the six million people in the US affected by anaemia of chronic kidney disease.... Jul 17
	Sanofi streamlines Consumer Healthcare portfolio in Latin America with divestiture of eight brands to Hypera Pharma As discussed during our Capital Markets Day in February, simplifying the CHC product portfolio is an important part of our strategy to focus our resources ... Jul 14
	Lupin Launches Tavaborole Topical Solution in the United States The product will be manufactured at Lupinâ€™s facility in Pithampur, India... Jul 14
	Stallergenes Greer and ALYATEC announce collaboration in allergen immunotherapy With this collaboration, Stallergenes Greer aims to strengthen its precision medicine-based approach ... Jul 12
	Standigm Secures Strategic Investment from SK Chemicals for Expanding its AI-Drug Development Capacity Pharma News update : Strategic Investments... Jul 05
	Dr. Reddyâ€™s Laboratories Announces Commercial Launch of 2DG 2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and ... Jun 28
	Forxiga recommended for approval in the EU by CHMP for the treatment of patients with chronic kidney disease If approved, Forxiga has the potential to change the treatment paradigm for millions of people in the EU suffering from chronic kidney disease... Jun 28
	Dr. Reddyâ€™s Laboratories Announces Commercial Launch of 2DG 2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and ... Jun 28
	Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy Recommendation based on positive results from the Phase 3 CheckMate -577 trial in which Opdivo doubled disease-free survival compared to placebo in the all-... Jun 25
	Bristol Myers Squibb Receives Positive CHMP Opinion for Anti-BCMA CAR T Cell Therapy Abecma for Relapsed and Refractory Multiple Myeloma ... Jun 25
	Glenmark Pharmaceuticals receives ANDA tentative approval for Nintedanib Capsules, 100 mg and 150 mg According to IQVIATM sales data for the 12 month period ending April 2021, the Ofev Capsules, 100 mg and 150 mg market achieved annual sales ... Jun 25
	Zydus Cadila receives tentative approval from USFDA for Pemetrexed for Injection Pemetrexed is used to treat certain types of cancers such as lung cancer, mesothelioma. It is a chemotherapy drug that works by slowing or stopping ... Jun 25
25 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

Novartis India Limited signs exclusive sales and distribution agreement with Dr. Reddyâ€™s Laboratories

Asymchem Acquires Snapdragon Chemistry

Novo Nordisk announces completion of Dicerna Pharmaceuticals acquisition

Hyloris announces FDA acceptance of new drug application for Maxigesic IV in post-operative pain

Everest Medicines enters into agreement with Providence Therapeutics to advance mRNA vaccines and Therapies

Precision BioSciences and Tiziana Life Sciences announce exclusive license agreement to evaluate Foralumab

Dupixent significantly improved itch and hives in patients with chronic spontaneous urticaria

Biocon Biologics and Viatris Inc. Receive Historic Approval for First Interchangeable Biosimilar Semglee for the Treatment of Diabetes

Dupixent significantly improved itch and hives in patients with chronic spontaneous urticaria

Biocon Biologics and Viatris Inc. Receive Historic Approval for First Interchangeable Biosimilar Semglee for the Treatment of Diabetes

BioNTech to acquire Kiteâ€™s neoantigen TCR Cell Therapy R&D platform and manufacturing facility in Gaithersburg, MD

Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma

Merck Announces U.S. FDA Approval of VAXNEUVANCE for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older

Status on FDA Advisory Committee vote on roxadustat in anaemia of chronic kidney disease

Sanofi streamlines Consumer Healthcare portfolio in Latin America with divestiture of eight brands to Hypera Pharma

Lupin Launches Tavaborole Topical Solution in the United States

Stallergenes Greer and ALYATEC announce collaboration in allergen immunotherapy

Standigm Secures Strategic Investment from SK Chemicals for Expanding its AI-Drug Development Capacity

Dr. Reddyâ€™s Laboratories Announces Commercial Launch of 2DG

Forxiga recommended for approval in the EU by CHMP for the treatment of patients with chronic kidney disease

Dr. Reddyâ€™s Laboratories Announces Commercial Launch of 2DG

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy

Bristol Myers Squibb Receives Positive CHMP Opinion for Anti-BCMA CAR T Cell Therapy Abecma for Relapsed and Refractory Multiple Myeloma

Glenmark Pharmaceuticals receives ANDA tentative approval for Nintedanib Capsules, 100 mg and 150 mg

Zydus Cadila receives tentative approval from USFDA for Pemetrexed for Injection

Trending Now